Are there primary intraocular lymphomas that do not develop into central nervous system lymphomas?

Area of Science:

• Ophthalmology
• Neurology
• Oncology

Background:

• Primary intraocular lymphoma (IOL) often co-occurs with or progresses to central nervous system lymphoma (CNSL).
• Understanding the relationship and progression between IOL and CNSL is crucial for patient management.

Purpose of the Study:

• To investigate the incidence and timing of central nervous system lymphoma development in patients initially diagnosed with primary intraocular lymphoma.
• To evaluate the role of CD5 immunostaining in predicting CNSL involvement.

Main Methods:

• Retrospective review of 22 consecutive patients diagnosed with primary intraocular lymphoma via immunostaining of vitrectomy cell blocks.
• Analysis of patient records for subsequent development of central nervous system lymphoma.
• Examination of CD5 immunostaining results in relation to CNSL development.

Main Results:

• Seventeen out of 22 patients developed central nervous system lymphoma, either simultaneously, after, or preceding the intraocular diagnosis.
• Five patients did not develop CNSL within the follow-up period, with two showing no recurrence after vitrectomy alone.
• CD5 immunostaining results (positive or negative) did not correlate with the development of central nervous system lymphoma.

Conclusions:

• Primary intraocular lymphoma has a high propensity to involve the central nervous system.
• Vitrectomy alone may be sufficient for some patients, but long-term surveillance for CNSL is essential.
• CD5 is not a reliable biomarker for predicting central nervous system involvement in primary intraocular lymphoma.